Buclin T, Burnand B, Biollaz J
Division de pharmacologie et toxicologie cliniques, Hôpital de Beaumont CHUV, Lausanne.
Rev Med Suisse. 2006 Apr 12;2(61):992-6.
During recent years, an increasingly comprehensive set of rules and guidelines has been developed around clinical trials, to ensure their proper ethical, methodological, administrative and financial conduct. While initially limited to new drug development, this regulation is progressively invading all areas of clinical research, with limited respect for the heterogeneity in aims, resources, sponsors and epistemological grounds. No clinical study should be planned without consideration of a series of legal requirements, which are reviewed. Concerns about their practical implications are critically assessed.
近年来,围绕临床试验制定了一套越来越全面的规则和指南,以确保其在伦理、方法、管理和财务方面的适当实施。虽然最初仅限于新药研发,但这种监管正逐渐渗透到临床研究的所有领域,而对目标、资源、赞助商和认识论基础的异质性考虑有限。在规划任何临床研究时都应考虑一系列法律要求,并对其进行审查。同时,对这些要求的实际影响进行批判性评估。